KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Tax Provisions: 2009-2025

Historic Tax Provisions for Tenet Healthcare (THC) over the last 17 years, with Q3 2025 value amounting to $133.0 million.

  • Tenet Healthcare's Tax Provisions fell 4481.33% to $133.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $516.0 million, marking a year-over-year decrease of 5739.06%. This contributed to the annual value of $1.2 billion for FY2024, which is 28692.81% up from last year.
  • According to the latest figures from Q3 2025, Tenet Healthcare's Tax Provisions is $133.0 million, which was down 4481.33% from $120.0 million recorded in Q2 2025.
  • Tenet Healthcare's 5-year Tax Provisions high stood at $750.0 million for Q1 2024, and its period low was $45.0 million during Q1 2021.
  • Moreover, its 5-year median value for Tax Provisions was $99.0 million (2022), whereas its average is $139.0 million.
  • In the last 5 years, Tenet Healthcare's Tax Provisions soared by 79285.71% in 2024 and then tumbled by 8093.33% in 2025.
  • Over the past 5 years, Tenet Healthcare's Tax Provisions (Quarter) stood at $108.0 million in 2021, then crashed by 56.48% to $47.0 million in 2022, then surged by 34.04% to $63.0 million in 2023, then skyrocketed by 31.75% to $83.0 million in 2024, then skyrocketed by 60.24% to $133.0 million in 2025.
  • Its Tax Provisions stands at $133.0 million for Q3 2025, versus $120.0 million for Q2 2025 and $143.0 million for Q1 2025.